Trial Profile
Evaluation of drug-drug interaction between cytochrome P450 substrate Selexipag and Clopidogrel in human
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2020
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Selexipag (Primary)
- Indications Arteriosclerosis obliterans; Pulmonary arterial hypertension; Pulmonary hypertension; Raynaud's disease; Spinal stenosis
- Focus Pharmacokinetics
- 30 Sep 2020 Status changed to completed, results published in the British Journal of Clinical Pharmacology
- 30 Sep 2020 Results published in the British Journal of Clinical Pharmacology
- 16 Oct 2018 Status changed from not yet recruiting to recruiting.